Vertex Pharmaceuticals (VRTX) Goodwill (2009 - 2026)

Vertex Pharmaceuticals' Goodwill history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• On a quarterly basis, Goodwill changed 0.0% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 0.0% change from a year earlier, with the FY2025 full-year figure at $1.1 billion, changed 0.0% from the prior year.
• Goodwill held at $1.1 billion in Q1 2026 per VRTX's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Goodwill topped out at $1.1 billion in Q4 2023 and bottomed at $1.0 billion in Q1 2022.
• The 5-year median for Goodwill is $1.1 billion (2022), against an average of $1.1 billion.
• Across the five-year window, Goodwill gained 8.8% in 2022 and retreated 1.09% in 2024, its largest moves.
• Year by year, Goodwill stood at $1.1 billion in 2022, then gained by 1.1% to $1.1 billion in 2023, then retreated by 1.09% to $1.1 billion in 2024, then changed by 0.0% to $1.1 billion in 2025, then changed by 0.0% to $1.1 billion in 2026.
• Per Business Quant, the three latest VRTX Goodwill figures stand at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).